No to hattatsu. Brain and development 2013-09-01

[Epileptic encephalopathy associated with forced normalization after administration of levetiracetam].

Takahiro Kikuchi, Mitsuhiro Kato, Nobuya Takahashi, Kazuyuki Nakamura, Kiyoshi Hayasaka

Index: No To Hattatsu. 45(5) , 375-8, (2013)

Full Text: HTML

Abstract

Here we report a case of a 10-year-old female with unclassified epileptic encephalopathy who showed forced normalization after administration of levetiracetam (LEV). She initially presented with intractable tonic and myoclonic seizures that were observed about 10 times a day along with frequent multifocal sharp and slow wave complexes on electroencephalography (EEG). We were forced to decrease the topiramate dose because of the appearance of nystagmus, and her myoclonic seizures became worse. We added LEV (250 mg/day) and her tonic and myoclonic seizures disappeared one day after initiation of LEV administration. However, she showed hyporesponsiveness and akinesia. The disappearance of paroxysmal discharges on EEG confirmed the diagnosis of forced normalization. Despite continuous administration of LEV, tonic and myoclonic seizures relapsed within a month but her psychotic symptoms resolved simultaneously. To the best of our knowledge, this is the first reported case of forced normalization after LEV administration. It should be noted that LEV may cause forced normalization although it can be started at an adequate dosage.


Related Compounds

  • Piracetam
  • Etiracetam
  • Etiracetam
  • Levetiracetam

Related Articles:

Reconstituted mother tinctures of Gelsemium sempervirens L. improve memory and cognitive impairment in mice scopolamine-induced dementia model.

2015-01-15

[J. Ethnopharmacol. 159 , 274-84, (2014)]

Chemical genetics reveals a complex functional ground state of neural stem cells.

2007-05-01

[Nat. Chem. Biol. 3(5) , 268-273, (2007)]

Screening for impact of popular herbs improving mental abilities on the transcriptional level of brain transporters.

2014-06-01

[Acta. Pharm. 64(2) , 223-32, (2014)]

Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors.

2010-03-11

[J. Med. Chem. 53 , 2197-203, (2010)]

Inhibition of excitatory synaptic transmission in hippocampal neurons by levetiracetam involves Zn²⁺-dependent GABA type A receptor-mediated presynaptic modulation.

2014-02-01

[J. Pharmacol. Exp. Ther. 348(2) , 246-59, (2014)]

More Articles...